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Abstract 
High circulating glucose and free fatty acid levels can cause pancreatic beta cell failure. The 
molecular mechanisms of this beta cell glucolipotoxicity are yet to be established 
conclusively. Here we report on the involvement of mitochondrial dysfunction in fatty acid-
induced beta cell failure. We have used state-of-the-art extracellular flux technology to 
functionally probe mitochondrial energy metabolism in intact INS-1E insulinoma cells in 
real-time. We show that 24-hr palmitate exposure at high glucose attenuates the glucose-
sensitivity of mitochondrial respiration and lowers coupling efficiency of glucose-stimulated 
oxidative phosphorylation. These mitochondrial defects coincide with an increased level of 
reactive oxygen species (ROS), impaired glucose-stimulated insulin secretion (GSIS) and 
decreased cell viability. Palmitate lowers absolute glucose-stimulated respiration coupled to 
ATP synthesis, but does not affect mitochondrial proton leak. Palmitate is not toxic when 
administered at low glucose unless fatty acid beta oxidation is inhibited. Palmitoleate, on the 
other hand, does not affect mitochondrial respiration, ROS levels, GSIS or cell viability. 
Whilst palmitoleate protects against the palmitate-induced ROS increase and cell viability 
loss, it does not protect against respiratory and insulin secretory defects. We conclude that 
mitochondrial dysfunction contributes to fatty acid-induced GSIS impairment, and that 
glucolipotoxic cell viability and GSIS phenotypes are mechanistically distinct. 
 
Keywords 
pancreatic beta cell glucolipotoxicity, glucose-stimulated insulin secretion, mitochondrial 
dysfunction, oxidative phosphorylation, reactive oxygen species, type 2 diabetes 
 
Summary Statement 
Obesity-related pancreatic beta cell failure contributes to development of type 2 diabetes. We 
show that defects in mitochondrial oxidative phosphorylation largely account for fatty acid-
induced impairment of glucose-stimulated insulin secretion, but not for the lipotoxicity-
related loss of beta cell viability. 
 
#Abbreviations 
CPT-1, carnitine palmitoyltransferase-1; FBS, fetal bovine serum; GSIS, glucose-stimulated 
insulin secretion; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; MitoSOX, 
mitochondria-targeted hydroethidine; NEFA, non-esterified fatty acid; ROS, reactive oxygen 
species; UCP2, uncoupling protein-2 
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INTRODUCTION 
The risk of developing type 2 diabetes is greatly increased in obese individuals [1] and a 
major mediator of this risk is a chronic elevation of circulating non-esterified fatty acids 
(NEFAs#) [2].  It is generally accepted that there is a causal relationship between chronically 
high NEFA levels and pancreatic beta cell failure. This pathological link, which is often 
referred to as ‘beta cell lipotoxicity’ [3], is responsible for the impaired insulin secretion that 
contributes to the development of obesity-related hyperglycaemia [4]. 
The precise mechanisms by which NEFAs lead to beta cell failure are subject of 
ongoing debate, which is partly due to the relatively complicated nature of lipotoxicity [5,6]. 
Exposure time, for example, is a critical factor that determines whether or not a particular 
fatty acid will be detrimental (long exposure) for beta cell performance or in fact beneficial 
(short exposure). It is worth stressing in this respect that the exposure necessary for toxic 
effects is poorly defined and varies dramatically between experimental systems ranging from 
a few hours in cultured cell models to many years in human subjects [5]. Moreover, not all 
fatty acids are equal as it has been reported that the toxic effect of NEFAs on beta cells 
depends on carbon chain length and double bond configuration [7]. Long-chain saturated 
NEFAs such as palmitate are generally harmful to beta cells, whereas unsatured molecules 
such as palmitoleate are relatively well tolerated and may even protect against the adverse 
effects of their saturated equivalents [7]. Importantly, even chronic exposure to high levels of 
saturated NEFAs is not necessarily harmful to beta cells, as toxicity often depends on a high 
glucose level – given this glucose permissibility, lipotoxicity is more correctly referred to as 
‘glucolipotoxicity’ [8]. 
Glucolipotoxicity is an umbrella term that covers the combined deleterious effects of 
supraphysiological glucose and NEFA levels on both the viability and function of pancreatic 
beta cells [5]. Cellular defects that may be responsible for NEFA-induced beta cell death [9] 
or loss of insulin secretory function [10], are in abundance: glucolipotoxicity has for example 
been associated with regulatory gene transcription changes [11], epigenetic alterations [12], 
inflammation [13], defected cell signalling [14], oxidative stress [15], endoplasmic reticulum 
stress [16], and with mitochondrial dysfunction [17]. However, the relative importance of 
these multifarious NEFA effects and, indeed, their causal relations are unclear at present. 
Some important mechanistic questions are yet to be answered too. For example, anabolic 
derivatives, which likely emerge from the glycerolipid/free fatty acid cycle [18], are widely 
held responsible for the detrimental effects of fatty acids, but the nature of such derivatives 
remains elusive [5]. The mechanism by which unsaturated NEFAs offer cytoprotection 
against the harmful effects of their saturated equivalents remains equally obscure [19] and, 
although such protection prevents cellular death [7], it is unclear if it equally applies to the 
many other glucolipotoxic effects. 
Following the observation that mitochondrial uncoupling protein-2 (UCP2) dampens 
glucose-stimulated insulin secretion (GSIS) in mouse islets [20], mitochondrial dysfunction 
has been linked causally to beta cell glucolipotoxicity and development of type 2 diabetes 
[17]. However, the GSIS improvement observed in mice after global UCP2 knockout on a 
mixed genetic background [20] is fully lost when the protein is knocked out on congenic 
backgrounds [21]. Instead, genetically pure mice exhibit impaired GSIS, which has been 
attributed to the persistent oxidative stress such animals face [21]. Given these results, the 
UCP2 upregulation observed under glucolipotoxic conditions was interpreted as a stress 
response preventing fuel-induced oxidative damage [15], probably by allowing proton leak 
across the mitochondrial inner membrane [22,23]. Recent studies with pancreatic islets 
isolated from beta cell-specific UCP2 knockout mice [24] and INS-1E insulinoma cells [23] 
show that UCP2 attenuates GSIS and lowers reactive oxygen species (ROS) levels. These 
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findings are consistent with a dual role for UCP2 in GSIS regulation and oxidative stress 
protection. Whilst the UCP2 role in glucolipotoxicity is yet to be established firmly [5], it is 
likely that other defects in mitochondrial function contribute to the harmful NEFA effects on 
beta cell function and viability [25]. When possible mitochondrial dysfunction is explored in 
cells [26], it is generally important to define explicitly which aspects of mitochondrial 
physiology are important for the specific function of a given cell. In pancreatic beta cells, 
glucose-sensitivity of respiration and the coupling between respiration and ATP synthesis are 
two features of mitochondrial function that are essential for triggering GSIS (Fig. 1A, [27]). 
Furthermore, ROS that are involved in non-canonical GSIS [28] are at least partly 
mitochondria-derived [23]. 
In the study reported here, we have exploited extracellular flux technology to probe 
mitochondrial function in INS-1E insulinoma cells [29] that were exposed to glucolipotoxic 
conditions that cause loss of cell viability and GSIS impairment. By comparing the effects of 
palmitate and its monounsaturated counterpart palmitoleate on basal mitochondrial 
respiration and both glucose-sensitivity and coupling efficiency of oxidative phosphorylation 
we show that (i) mitochondrial dysfunction contributes significantly to palmitate-induced 
GSIS defects, (ii) palmitate-provoked viability and GSIS phenotypes are mechanistically 
distinct, (iii) proton leak does not contribute to palmitate-induced mitochondrial dysfunction, 
and (iv) fatty acid beta oxidation restricts palmitate-induced mitochondrial dysfunction. 
EXPERIMENTAL 
Cell Culture 
INS-1E insulinoma cells were maintained in RPMI-1640 medium containing 11 mM glucose, 
5% (v/v) fetal bovine serum (FBS), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), 1 mM sodium pyruvate, 50 U/mL penicillin, 50 µg/mL streptomycin, 500 µM 
β-mercaptoethanol and 2 mM L-glutamine [30]. Cells were seeded at 60,000 cells/well and, 
at 70-80% confluence, exposed to NEFAs for 24 hr in serum-free RPMI containing 4 or 11 
mM glucose. NEFA exposure at low glucose was executed ± 50 µM etomoxir. NEFAs were 
conjugated to bovine serum albumin (BSA), so control cells were exposed to BSA alone. 
NEFA-BSA conjugation 
Fatty acid-free BSA (Sigma A7030) was dissolved at 1.6 mM in medium containing 135 mM 
NaCl, 3.6 mM KCl, 10 mM HEPES (pH 7.4), and 0.5 mM MgCl2. Palmitate (8 mM), 
palmitoleate (3.5 mM) or a combination of palmitate (5.5 mM) and palmitatoleate (1 mM) 
were added as powder or liquid, respectively, and stirred continuously at 35-38 ˚C for 1 hr or 
until all NEFAs had dissolved. Cooled BSA:NEFA conjugations were filter-sterilised and 
stored at 4 ˚C. When added to cultures, BSA:NEFA mixtures were diluted 40x. The applied 
BSA and NEFA concentrations were chosen because of published binding parameters [31] 
that predict the respective molar ratios should result in similar total unbound NEFA levels. 
Insulin secretion 
Cells were seeded and exposed to NEFAs on 96-well culture plates and then starved for 2 h 
in RPMI lacking glucose and sodium pyruvate, and containing 1% (v/v) FBS. Cells were then 
washed with glucose-free Krebs-Ringer medium (KRH) comprising 135 mM NaCl, 3.6 mM 
KCl, 10 mM HEPES (pH 7.4), 0.5 mM MgCl2, 1.5 mM CaCl2, 0.5 mM NaH2PO4, 2 mM 
glutamine, and 0.1% (w/v) BSA and incubated in this medium for 30 min at 37 oC on a 
shaking plate incubator (Labnet International, Oakham, UK) set at 100 rpm. Next, glucose-
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free KRH was replaced with KRH containing 0-28 mM glucose or 4 mM glucose and 50 mM 
KCl. After another 30 min incubation, supernatants were collected, centrifuged to pellet any 
detached cells, and assayed for insulin by ELISA (Mercodia, Uppsala, Sweden) using mouse 
insulin as standard. 
Mitochondrial bioenergetics 
Mitochondrial function was measured in intact attached INS-1E cells as described before [29]. 
Cells seeded and NEFA-exposed on XF24 culture plates (Seahorse Bioscience) were washed 
in glucose-free KRH lacking BSA and incubated in this medium for 30 min at 37 oC under air.  
Plates were transferred to a Seahorse XF24 extracellular flux analyser (controlled at 37 ˚C) 
for a 10-min calibration and 4 measurement cycles to record basal cellular respiration (Figs 
1B and 1C). Up to 28 mM glucose was then added to stimulate respiration and, subsequently, 
5 µg/mL oligomycin and a mixture of 1 µM rotenone plus 2 µM antimycin A were added to, 
respectively, inhibit the ATP synthase and to determine non-mitochondrial respiration. 
Mitochondrial ROS 
ROS levels were estimated from MitoSOX oxidation rates as described previously [23,32]. 
Cells seeded and NEFA-exposed on 96-well plates were washed in glucose-free KRH lacking 
BSA, incubated in this medium for 30 min at 37 oC under air, and were then transferred to a 
multimode plate reader (PHERAstar FS BMG LABTECH). Following injection of 5 µM 
MitoSOX (Invitrogen M36008), fluorescence was monitored at 28-sec intervals for 30 min. 
The fluorescent MitoSOX oxidation products were excited at 510 nm and light emission was 
detected at 580 nm. The plate reader’s focal height was set at 3.4 mm and its gain was fixed 
between different experiments. 
Cell density 
Cell densities were determined to quantify NEFA effects on cell viability and to normalise 
data. For both purposes, the metabolic activity of INS-1E cells was probed on Seahorse XF24 
plates by adding 50 nM C12-resazurin in 100 µL RPMI to each well [32]. Shielded from light, 
the plate was then incubated for 50 min at 37 oC / 5% CO2. Metabolically active cells reduce 
C12-resazurin to the fluorescent C12-resorufin (λex/em = 540/590 nm), which was detected 
using a PHERAstar FS plate reader (BMG LABTECH) in fluorescence intensity, bottom-
reading and well-scanning mode. For the normalisation of respiratory data (Figs 2A and 4), 
KRH was replaced with RPMI containing C12-resazurin immediately after measuring basal 
oxygen uptake, i.e., in the absence of any respiratory effectors. The respiratory activity in a 
particular well was normalised using the cell density measured in that same well [32]. 
MitoSOX oxidation data (Fig. 5) were normalised using averaged cell viabilities (Fig. 7). 
Statistical analysis 
Significance of mean differences was tested by ANOVA – applying Tukey’s multiple 
comparison post-hoc analysis – using GraphPad Prism Version 6.0 for Mac OS X (GraphPad 
software, San Diego, CA, USA). 
RESULTS 
Mitochondrial respiration 
When blood glucose rises, beta cells increase their oxidative catabolism of glucose, which 
leads to increased mitochondrial respiratory activity that is coupled to ATP synthesis (Fig. 
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1A). In canonical GSIS, the glucose-induced increase in the ATP/ADP ratio is the key signal 
that triggers insulin release [33]. The typical respiratory trace shown in Fig. 1B illustrates that 
INS-1E cells indeed increase their oxygen uptake rate, by about 50%, when subjected to 28 
mM glucose. This cellular respiratory response to glucose is dampened to an approximately 
25% increase (Fig. 1C) in cells that were exposed for 24 hr to palmitate in the presence of 11 
mM glucose. As expected, the oxygen consumption of control and palmitate-exposed cells is 
inhibited by both oligomycin and a mixture of rotenone and antimycin A (Figs 1B and 1C). 
The data shown in Figs 1B and 1C are normalised to basal respiration measured in the 
absence of glucose. When corrected for non-mitochondrial oxygen uptake, which ranges 
from 0.5 to 0.6 fmol O2/min/cell (Fig. 2A), the magnitude of this basal respiration is 2 fmol 
O2/min/cell (Fig. 2A). Exposure to palmitate or palmitoleate, alone or combined, does not 
significantly affect either the basal mitochondrial or non-mitochondrial respiratory rates (Fig. 
2A). However, at 11 mM glucose, palmitate exposure lowers the glucose sensitivity of 
mitochondrial respiration (Fig. 2B). Basal mitochondrial oxygen consumption of control cells 
increases up to 2-fold when 4-28 mM glucose is administered, whereas oxygen consumption 
of palmitate-exposed cells increases maximally 1.2-fold. Similar exposure to palmitoleate 
does not affect glucose-sensitivity of INS-1E mitochondrial respiration, and palmitoleate 
does not provide significant protection against the desensitising effect of palmitate (Fig. 2B). 
When exposed at 4 mM glucose, palmitate and palmitoleate, alone or combined, do not 
significantly affect the mitochondrial respiratory response to glucose (Fig. 1C). Probably due 
to differential glucose limitation, BSA control cells incubated at low glucose (Fig. 1C) tend to 
respond somewhat more strongly to glucose than cells exposed at high glucose (Fig. 1B). 
Coupling efficiency 
Coupling efficiency of oxidative phosphorylation is defined as the proportion of 
mitochondrial respiration linked to ATP synthesis [26]. Coupling efficiency can be 
approximated from the oligomycin-sensitivity of mitochondrial oxygen consumption [29] and 
may thus be derived from data as shown in Fig. 1. Because the inner membranes of INS-1E 
mitochondria allow an unusually high proton leak [34], INS-1E cells exhibit exceptionally 
low coupling efficiency [22,23] as is reflected by Fig. 3A, which shows that control cells use 
just 50-55% of their glucose-stimulated mitochondrial respiratory activity to make ATP. 
Interestingly, palmitate exposure at high glucose lowers the coupling efficiency further, such 
that only 40% of the respiratory activity drives ATP synthesis at any applied glucose level 
(Fig. 3A). Palmitoleate exposure causes a small, statistically insignificant, rise in coupling 
efficiency (Fig. 3A). Mirroring the NEFA effects on the glucose-sensitivity of mitochondrial 
respiration (Fig. 2), palmitoleate does not protect against the negative effect of palmitate on 
coupling efficiency (Fig. 3A), and palmitate nor palmitoleate lower coupling efficiency when 
incubated at low glucose (Fig. 3B). 
 Coupling efficiency reflects all major processes underlying oxidative phosphorylation 
including substrate oxidation, ADP phosphorylation and proton leak across the mitochondrial 
inner membrane [29]. The detrimental palmitate effect at high glucose exposure on coupling 
efficiency (Fig. 3A) could, therefore, in principle be due to inhibitory effects on substrate 
oxidation and/or ADP phosphorylation, and/or to a stimulatory effect on proton leak. To 
distinguish between these possibilities, we calculated the absolute total glucose-stimulated 
respiratory activity (substrate oxidation) as well as absolute oligomycin-sensitive (ADP 
phosphorylation) and oligomycin-resistant (proton leak) activities. Fig. 4 shows that palmitate 
exposure causes statistically significant drops in both the total and the oligomycin-sensitive 
glucose-stimulated mitochondrial respiratory activities, indicating that ADP phosphorylation-
coupled substrate oxidation has been compromised. Palmitoleate exposure lowers neither 
substrate oxidation nor ADP phosphorylation, but instead causes a small, statistically 
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insignificant, stimulation of these processes (Fig. 4). Importantly, proton leak is not affected 
by exposure to palmitate and/or palmitoleate (Fig. 4). 
Mitochondrial ROS 
In addition to their textbook role in GSIS (Fig. 1A), mitochondria play an important part in 
less well understood, non-canonical GSIS mechanisms [35]. For example, ROS have been 
implicated as insulin secretion signals [28], and at least some of these ROS are mitochondria-
derived [23]. To assess the effect of NEFAs on mitochondrial ROS, we probed MitoSOX 
oxidation in cells exposed to palmitate and palmitoleate, alone or in combination, at 11 or 4 
mM glucose (Fig. 5). MitoSOX is a mitochondria-targeted hydroethidine analogue that is 
oxidised mainly by superoxide, but also by hydrogen peroxide [36]. The MitoSOX oxidation 
rate, calculated from fluorescence progress curves (Figs 5A and B), is thus proportional to 
mitochondrial ROS levels. The data shown in Fig. 5C reveal that palmitate exposure at 11 
mM glucose causes a significant rise in ROS, whereas the equivalent palmitoleate exposure is 
without effect. Interestingly, palmitoleate dampens the palmitate-induced ROS increase (Fig. 
5C). Palmitate nor palmitoleate stimulate ROS when cells are exposed at 4 instead of 11 mM 
glucose. The mechanism by which palmitate increases mitochondrial ROS at high glucose is 
unclear at present. Pancreatic beta cells contain NADPH oxidases, however, that produce 
cytoplasmic superoxide [37], which is likely detected by MitoSOX that has not accumulated 
into the mitochondrial matrix [36]. Consistent with our data, the expression of a key NADPH 
oxidase component is increased by palmitate [38]. Irrespective of their origin, palmitoleate 
lowers palmitate-induced ROS significantly (Fig. 5C). This apparent palmitoleate protection 
against oxidative stress disconnects the effect of palmitate on ROS (Fig. 5) from its effects on 
oxidative phosphorylation (Figs 2-4). 
GSIS and cell viability 
To assess if the palmitate-induced defects in oxidative phosphorylation (Figs 2-4) and rise in 
ROS (Fig. 5) relate to any other lipotoxic effects, we measured insulin release (Fig. 6) and 
cell viability (Fig. 7). INS-1E insulin secretion is stimulated considerably by glucose, which 
is why this insulinoma cell line is widely used as beta cell model [30]. In our hands, basal 
INS-1E insulin secretion is more than doubled by high glucose and increased 1.6-fold by KCl 
(Fig. 6A). Although these responses are somewhat lower than those reported elsewhere [30], 
they nonetheless allow NEFA effects to be assessed. Palmitate exposure at 11 mM glucose 
blunts both glucose- (Fig. 6B) and KCl-stimulated (Fig. 6C) insulin secretion completely, 
although the effect on KCl-induced secretion appears not statistically significant. 
Palmitoleate exposure at high glucose, on the other hand, has no significant effect on GSIS 
(Fig. 6B) or KCl-induced insulin release (Fig. 6C). Importantly, the deleterious effects of 
palmitate on GSIS (Fig. 6B) and KCl-induced insulin secretion (Fig. 6C) are not prevented 
significantly by palmitoleate. This lack of protection mirrors the relative inconsequentiality of 
palmitoleate with respect to palmitate-induced defects in oxidative phosphorylation (Figs 2-4). 
Similar to the bioenergetic phenotypes, the lipotoxic GSIS effects also depend on the 
presence of a relatively high glucose level, since palmitate exposure at low glucose does not 
impair GSIS (Fig. 6D). Reminiscent of the mitochondrial respiratory response to glucose 
(Figs 1B, 1C), GSIS in BSA control cells is a little, but not significantly, higher at 4 mM than 
at 11 mM glucose (Figs 6D, 6B). Interestingly, palmitoleate exposure at low glucose, either 
alone or combined with palmitate, tends towards GSIS potentiation (Fig. 6D).  
 In line with the ROS, GSIS and mitochondrial respiratory effects, palmitate exposure 
at high glucose lowers cell viability (cell survival < 40%), whereas palmitoleate is relatively 
harmless (Fig. 7A). Palmitate and/or palmitoleate do not cause statistically significant cell 
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loss when administered at low glucose (Fig. 7B), which mirrors the glucose dependence of 
the ROS, GSIS and bioenergetic effects. Unlike the GSIS and bioenergetic phenotypes, 
palmitoleate protects against palmitate-induced cell loss at high glucose exposure (Fig. 7A). 
Such protection is indeed consistent with the prevention by palmitoleate of palmitate-induced 
ROS (Fig. 5C). NEFA effects on cell survival are also seen when viability is probed with 
nuclear instead of metabolic indicators (not shown). 
Mitochondrial palmitate toxicity at low glucose 
Palmitate only causes harm to INS-1E cells when administered at high glucose (Figs 2-3, 5-7). 
This exclusivity is likely explained by the Randle ‘cycle’ [39]: high glucose oxidation leads 
to accumulation of cytoplasmic malonyl-CoA, which inhibits carnitine palmitoyltransferase-1 
(CPT1) thus preventing mitochondrial beta oxidation of fatty acids and promoting NEFA 
engagement in esterification-hydrolysis cycles [18] – this order of events is generally held 
responsible for the glucose permissibility of lipotoxicity [8]. To test if palmitate-induced 
effects on mitochondrial respiration would be enhanced when its breakdown were prevented, 
we exposed INS-1E cells to palmitate at low glucose in the presence of etomoxir, a specific 
CPT1 inhibitor [40] that inhibits acute palmitate oxidation by INS-1E cells [35]. Fig. 8A 
shows that ‘BSA-etomoxir’ control cells increase mitochondrial respiration about 2.2-fold in 
response to 28 mM glucose. The equivalent response by ‘palmitate-etomoxir’ cells is just a 
1.7-fold rise (Fig. 8A). Cells exposed to BSA at low glucose in the absence of etomoxir 
respond to 28 mM glucose by increasing mitochondrial oxygen uptake roughly 2.5-fold – this 
response is not affected by palmitate (Figs 8A and 2C). The respiratory response to 28 mM 
glucose by cells exposed to BSA at high glucose, is lowered by palmitate from a 2-fold to a 
1.2-fold stimulation (Figs 8A and 2B). Fig. 8A thus demonstrates that statistically significant 
palmitate toxicity arises at low glucose when NEFA catabolism is impeded. The emerging 
palmitate lipotoxicity on glucose-sensitivity of mitochondrial respiration becomes even more 
apparent when glucose responses are normalised to the respective BSA control responses (Fig. 
8B). Interestingly, etomoxir’s presence at low glucose exposure does not allow the palmitate-
induced drop in coupling efficiency – assayed at 28 mM glucose – that is seen at high glucose 
exposure (Fig. 8C, cf. Fig. 3). The limited mitochondrial dysfunction caused by palmitate at 
low glucose in the presence of etomoxir, suggests that palmitate inhibits glucose oxidation at 
multiple targets that have different affinities for palmitate or its toxic derivative(s). 
DISCUSSION 
Mitochondrial dysfunction contributes to palmitate-induced GSIS defects 
Our functional bioenergetic analysis reveals that palmitate impairs aspects of mitochondrial 
function that underpin the insulin secretion ability of INS-1E cells: both glucose-sensitivity of 
mitochondrial respiration and coupling efficiency of oxidative phosphorylation are lowered 
(Figs 2B, 3A). Our results thus demonstrate that mitochondrial dysfunction contributes to the 
NEFA-induced GSIS defects reported by us (Fig. 6B) and others [10]. Agreeing with current 
concensus [5], the deleterious palmitate effects on mitochondrial function and GSIS depend 
on glucose (Figs 2C, 3B, 6D) and are, therefore, glucolipotoxic effects [8]. Functional insight 
in mitochondrial NEFA effects is scarce, but a recent study [12] associates palmitate-induced 
GSIS defects in INS-1 cells with (epi)genetic and metabolic changes, including diminished 
mitochondrial respiration. Consistent with our findings (Fig. 4), palmitate lowers glucose-
stimulated oxygen uptake coupled to phosphorylation, but does not affect proton leak [12]. 
Discrepant with our findings (Figs 2B, 3A), most likely because of experimental differences, 
palmitate does not seem to affect normalised glucose-sensitivity of mitochondrial respiration 
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or coupling efficiency [12]. Palmitate exposure leads to a significantly increased ROS level 
(Fig. 5). Palmitate-induced ROS likely arise from cytoplasmic NADPH oxidase activity [38], 
although it remains of course possible that some or all of these ROS have a mitochondrial 
origin. Irrespective of where they arise, however, palmitate-induced ROS do almost certainly 
not contribute to impaired GSIS, because palmitoleate prevents the emergence of these ROS 
(Fig. 5C), whereas this unsaturated NEFA does not protect against palmitate-induced GSIS 
defects (Fig. 6B). Although our data demonstrate involvement of mitochondrial dysfunction 
in palmitate-induced GSIS impairment, palmitate also likely acts on non-mitochondrial 
processes relevant to GSIS, e.g. KATP channel closure [41], Ca2+ channel opening [42] and 
exocytosis [43]. Attenuation of KCl-induced insulin release by palmitate (Fig. 6C) agrees 
with such non-mitochondrial action. 
 This paper highlights the power of measuring beta cell oxidative phosphorylation in 
real-time, revealing that mitochondrial function reliably predicts GSIS. Our approach is 
curently limited to cells, which is unfortunate, as pancreatic islets arguably yield more insight 
in glucolipotoxic pathophysiology than insulinoma cells. Respirometry has been applied to 
islets [24,44], but it is hard to causally link islet bioenergetics, which are accounted for by 
many cell types, to insulin secretion, which is mediated by beta cells alone [35]. Methods 
need to be developed to distinguish between the contributions of all cell types to islet 
respiration before we can probe the physiological impact of our data in a meaningful way. 
Reassuringly, our previous INS-1E predictions – high proton leak [22] and a dual UCP2 role 
in GSIS regulation and oxidative stress protection [23] – have come true in islets [15,24,44]. 
Glucolipotoxic viability and GSIS phenotypes are mechanistically distinct 
Unlike palmitate, palmitoleate does not increase ROS (Fig. 5) and does not compromise 
oxidative phosphorylation, insulin secretion or cell viability (Figs 2B, 3A, 6B, 7A). Instead, 
palmitoleate protects against palmitate-induced cell loss (Fig. 7A), which mirrors published 
data [7,45], and prevents a palmitate-induced rise in ROS (Fig. 5). Importantly, palmitoleate 
does not ameliorate palmitate-induced defects in oxidative phosphorylation (Figs 2B, 3A) and 
GSIS (Fig. 6B). Such differential palmitoleate protection suggests that the glucolipotoxic 
viability and GSIS phenotypes are mechanistically distinct: whereas blunted mitochondrial 
glucose-sensitivity and coupling efficiency at least partly account for GSIS impairment, these 
defects unlikely cause cell viability loss. NEFA-induced apotosis might result from other 
mitochondrial dysfunction [46], perhaps involving ROS (Fig. 5). Our results thus support the 
idea that the many and varied glucolipotoxic manifestations are not explained by one 
unifying mechanism [5] – the data also shed light on causal interrelations between the 
multifarious palmitate effects. 
 Some structural aspects critical to the cytoprotective properties of unsaturated NEFAs 
are known, and protection may involve endoplasmic reticulum stress responses, G-protein-
coupled receptors and NEFA esterification. Despite this knowledge, which has been reviewed 
expertly by others [6,7], the mechanism of cytoprotection remains elusive. Our data exclude 
mitochondrial oxidative phosphorylation from any mechanistic model, and thus weaken the 
reported idea [19] that unsaturated NEFAs enhance the clearance of saturated species by 
increasing beta oxidation. Moreover, our findings suggest that unsaturated NEFAs may 
indeed save beta cells from glucolipotoxic death, but they do not prevent functional 
deterioration of the surviving cells. 
Mechanism of palmitate-induced mitochondrial dysfunction 
UCP2 has been implicated in beta cell failure and development of type 2 diabetes [17], but its 
glucolipotoxic role is contentious [5]. Palmitate effects on glucose-sensitivity of respiration, 
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coupling efficiency, and GSIS (Figs 2B, 3A, 6B) closely mirror UCP2 effects on INS-1E 
cells reported before [23]. However, our results demonstrate that palmitate exposure does not 
affect mitochondrial proton leak (Fig. 4). This important observation most likely rules out 
UCP2 involvement in the mitochondrial dysfunction reported here, since UCP2 contributes 
considerably to proton leak of INS-1E cells [22,23]. Related, possible palmitate stimulation 
of UCP2 expression and/or activity is expected to increase overall mitochondrial respiration 
[22,23,47], which appears not the case (Fig. 2A). It remains unclear how palmitate exposure 
impedes glucose-fuelled oxidative phosphorylation, but multiple targets are likely [48]. 
Fatty acid beta oxidation restricts palmitate-induced mitochondrial dysfunction 
Palmitate blunts the mitochondrial respiratory response to glucose when administered at low 
glucose in the presence of etomoxir (Figs 8A, 8B). Such etomoxir-induced palmitate toxicity 
agrees with the widely accepted notion that malonyl CoA accumulation accounts for glucose 
permissibility of lipotoxicity [8]. Our observation predicts that NEFA toxicity at high glucose 
may be ameliorated by stimulating beta oxidation (Fig. 9), which would lower the chance that 
toxic NEFA derivatives emerge from esterification-hydrolysis cycles [18]. The stimulatory 
effect of palmitoleate – a relatively harmless NEFA – on absolute mitochondrial respiration 
(Fig. 4) supports this prediction, although the effect is statistically not significant. The 
relative ease, compared to their saturated counterparts, by which unsaturated NEFAs are 
anabolised to stable triglyceride [49] and thus removed from esterification-hydrolysis cycles, 
further explains the harmless nature of palmitoleate. Promotion of palmitate oxidation [19] 
and triglyceride formation [49] have both been suggested to explain the protective effect of 
unsaturated NEFAs against palmitate toxicity, but lack of palmitoleate protection against 
mitochondrial respiratory defects (Figs 2B, 3A, 4) weakens the ‘protection through oxidation’ 
model. 
 We hypothesise that harmful NEFA effects could be outweighed by beneficial effects 
that are triggered by NEFAs per se or by their catabolites (Fig. 9), and that the experimental 
phenotype of any NEFA exposure reflects the balance of these harmful and beneficial effects. 
Palmitate for example, acutely benefits beta cell function by potentiating GSIS [50] – we 
suggest that such potentiation is not seen after sustained exposure because palmitate toxicity 
dominates the phenotype time-dependently. This metabolic balance model explains why 24-
hr palmitate exposure impairs GSIS at high glucose and is inconsequential at low glucose and, 
at the same time, why palmitoleate is inconsequential at high glucose and in fact potentiates 
GSIS at low glucose even after 24-hr exposure (Figs 6B, 6D). We suggest that beneficial and 
deleterious NEFA processes are not necessarily separated in time, but may coincide. 
Conclusion 
Cellular bioenergetics yield powerful insight in pancreatic beta cell function as mitochondrial 
activity appears a reliable GSIS predictor. Our data have provided new information on some 
of the causal interrelations between the multifarious glucolipotoxicity phenotypes. However, 
the data also underscore the complicated nature of NEFA toxicity, suggesting many targets 
for even the damaging effect of palmitate on glucose oxidation alone. The occurrence of 
multiple targets hampers the development of drugs to manage NEFA-induced beta cell failure, 
but our findings suggest an alternative: as glucolipotoxicity may be ameliorated by promoting 
mitochondrial beta oxidation, stimulating such oxidation, perhaps via controlled uncoupling, 
may prove an attractive therapeutic possibility. 
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FIGURE LEGENDS 
Figure 1 – Real-time detection of palmitate-induced mitochondrial dysfunction in intact 
INS-1E cells. Panel A – Mitochondrial function is essential for canonical GSIS: glucose is 
taken up by pancreatic beta cells via an insulin-insensitive transporter (GLUT2) and broken 
down oxidatively, which leads to increased activity of the mitochondrial tricarboxylic acid 
(TCA) cycle and the mitochondrial respiratory chain (complexes I-IV), and an increased 
mitochondrial protonmotive force (pmf). The pmf drives ATP synthesis but may also be 
dissipated by mitochondrial uncoupling protein-2 (UCP2) activity. The glucose-induced rise 
in ATP/ADP triggers closure of ATP-sensitive potassium (KATP) channels, depolarization of 
the plasma membrane (Δψp), Ca2+ influx and exocytosis of insulin-containing granules. 
Panels B and C – Typical traces reflecting respiration of cells exposed for 24 hr at 11 mM 
glucose to BSA (Panel B) or BSA-conjugated palmitate (Panel C). Cellular oxygen uptake 
was measured as described in Experimental – 28 mM glucose (G28), 5 µg/mL oligomycin 
(OLI), and a mixture of 1 µM rotenone and 2 µM antimycin A (RA) were added as indicated. 
Data are means ± SEM of 5 separate wells from a single XF24 plate and are expressed as a 
percentage of basal respiration. 
Figure 2 – Palmitate exposure at high glucose dampens the glucose-sensitivity of 
mitochondrial respiration. Absolute basal mitochondrial and non-mitochondrial oxygen 
uptake (Panel A: dark-grey and light-grey bars, respectively), and glucose-sensitivity of 
mitochondrial respiration (Panels B and C) were measured in cells exposed for 24 hr to BSA-
conjugated NEFAs or BSA alone at 11 mM glucose (Panels A and B) or 4 mM glucose 
(Panel C). Data are means ± SEM of 3-5 independent experiments that each involved 3-4 
replicates per treatment. Statistical significance of mean differences for cells subjected to 28 
mM glucose was tested by 2-way ANOVA. Panel B – palmitate versus BSA: P < 0.001; 
palmitate + palmitoleate versus BSA: P < 0.05; palmitate versus palmitoleate: P < 0.01. 
Panel C – not significant. Panel B versus Panel C – BSA: not significant; palmitate: P < 
0.00001; palmitoleate: not significant; palmitate + palmitoleate: P < 0.01. Closed circles = 
BSA; closed triangles = palmitate; open triangles = palmitoleate; open squares = palmitate + 
palmitoleate. 
Figure 3 – Palmitate exposure at high glucose attenuates mitochondrial coupling 
efficiency. Coupling efficiency of oxidative phosphorylation – assayed at 4-28 mM glucose – 
was calculated as the percentage glucose-stimulated mitochondrial respiration sensitive to 
oligomycin in cells that had been exposed for 24 hr to BSA-conjugated NEFAs or BSA alone 
at 11 mM glucose (Panel A) or 4 mM glucose (Panel B). Data are means ± SEM from 3-5 
independent experiments that each involved 3-4 replicates per treatment. Statistical 
significance of mean differences for cells subjected to 28 mM glucose was tested by 2-way 
ANOVA. Panel A – palmitate versus BSA: P < 0.05; palmitate + palmitoleate versus BSA: P 
< 0.05; palmitate versus palmitoleate: P < 0.01. Panel B – not significant. Panel A versus 
Panel B – BSA: not significant; palmitate: P < 0.01; palmitoleate: not significant; palmitate + 
palmitoleate: P < 0.05. Closed circles = BSA; closed triangles = palmitate; open triangles = 
palmitoleate; open squares = palmitate + palmitoleate. 
Figure 4 – Palmitate exposure at high glucose decreases ADP phosphorylation-coupled, 
glucose-stimulated mitochondrial respiration but does not affect proton leak. Absolute 
total mitochondrial respiratory activity at 28 mM glucose (Total), and absolute oligomycin-
sensitive (Phosphorylation) and oligomycin-resistant (Leak) activities were calculated from 
cell number-normalised basal mitochondrial respiration (Fig. 2A), the sensitivity of basal 
mitochondrial respiration to 28 mM glucose (Fig. 2B), and the coupling efficiency of 
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oxidative phosphosphorylation at 28 mM glucose (Fig. 3A). Data are means ± SEM of 4 
separate experiments that each involved 3-4 replicates per treatment. Statistical significance 
of differences between groups was tested by 1-way ANOVA: * differs from ‘palmitate’ and 
‘palmitate + palmitoleate’ conditions (P < 0.05); *** differs from ‘palmitate’ and ‘palmitate 
+ palmitoleate’ conditions (P < 0.001). Dark-grey bars = BSA; open bars = palmitate; light-
grey bars = palmitoleate; black bars = palmitate + palmitoleate.  
Figure 5 – Palmitate exposure at high glucose increases ROS.  Mitochondrial superoxide 
was estimated from MitoSOX oxidation in INS-1E cells exposed for 24 hr to BSA-
conjugated NEFAs or BSA alone at 11 mM (Panel A) or 4 mM (Panel B) glucose. Panels A 
and B: MitoSOX (5 µM) was injected during the assay as indicated by the arrow and 
fluorescence was recorded at 28-sec intervals – for clarity, only a selection of measurements 
is shown. Relative fluorescence units (RFU) were corrected for low background fluorescence 
observed in cell-free controls and were normalised to cell number using averaged viability 
data shown in Fig. 7. Closed triangles = BSA; closed circles = palmitate; open diamonds = 
palmitoleate; open squares = palmitate + palmitoleate. Panel C: MitoSOX oxidation rates 
were calculated from the slopes of the progress curves shown in Panels A and B (dark-grey 
and light-grey bars = NEFA-exposure at 11 and 4 mM glucose, respectively). Except for the 
first 4 measurements, all data recorded following MitoSOX addition were included in these 
calculations. Data are means ± SEM of 3-6 independent experiments that involved 7-8 
replicates per treatment. Statistical significance of mean differences was tested by 2-way 
ANOVA: * differs from the equivalent palmitate condition (P < 0.05); ** differs from the 
equivalent palmitate condition (P < 0.01). 
Figure 6 – Palmitate exposure at high glucose impairs glucose-stimulated and KCl-
induced insulin secretion. Insulin secretion (ng/well/30 min) was measured in control cells 
grown in RPMI (Panel A) and in cells exposed for 24 hr to BSA-conjugated NEFAs or BSA 
alone at 11 mM glucose (Panels B and C) or 4 mM glucose (Panel D). Following glucose 
starvation, cells were subjected to 0-28 mM glucose (Panel A: G0, G4, G11, G28) or to 4 
mM glucose and 50 mM KCl (Panel A: KCl). GSIS was expressed as the G28/G0 insulin 
secretion ratio (Panels B and D) and KCl-induced insulin secretion was normalised to insulin 
secretion at 4 mM glucose (Panel C). Data are means ± SEM of 4-6 independent experiments 
that involved 4-5 replicates per treatment. Statistical significance of mean differences was 
tested by 1-way ANOVA: * differs from G0 condition (Panel A) or BSA condition (Panel B) 
(P < 0.05). 
Figure 7 – Palmitate exposure causes cell viability loss at high glucose. Cell viability was 
determined by measuring the total metabolic activity within individual culture plate wells 
(see Experimental) that contained cells exposed for 24 hr to BSA-conjugated NEFAs or BSA 
alone at 11 mM glucose (Panel A) or 4 mM glucose (Panel B). To quantify cell viability, 
total metabolic activity in each well was expressed as a percentage of the activity exhibited 
by wells that contained cells grown in fully supplemented RPMI – it was confirmed by light 
microscopy that these RPMI wells showed no signs of cell loss. Cell viability percentages 
were then normalised to the BSA controls. BSA alone causes about 5% and 20% cell loss 
when administered in serum-free RPMI at 11 and 4 mM glucose, respectively. Data are 
means ± SEM of 5-6 independent experiments that each involved 3-4 replicates per treatment. 
Statistical significance of mean differences was tested by 2-way ANOVA: ** differs from 
BSA and palmitoleate conditions (P < 0.01).  
Figure 8 – Mitochondrial toxicity of palmitate exposure emerges at low glucose when 
NEFA oxidation is inhibited. The glucose-sensitivity of mitochondrial respiration (Panels A 
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and B) and coupling efficiency of oxidative phosphorylation (Panel C) were measured in 
cells exposed for 24 hr to BSA-conjugated palmitate (grey bars) or BSA alone (dark-grey 
bars) at 11 mM glucose (G11), at 4 mM glucose (G4), or at 4 mM glucose with 50 µM 
etomoxir (G4+ETO). Mitochondrial respiration stimulated by 28 mM glucose was either 
normalised to basal respiration (Panel A) or to the respective glucose-stimulated BSA 
conditions (Panel B). Coupling efficiencies at 28 mM glucose were calculated as described in 
Experimental. Data are means ± SEM of 4-5 independent experiments that each involved 3-4 
replicates per treatment. Statistical significance of mean differences was tested by 2-way 
ANOVA: * differs from equivalent palmitate condition (P < 0.05); ** differs from equivalent 
G4 condition (P < 0.05). 
Figure 9 – A metabolic balance model of glucolipotoxicity. NEFA and glucose exposure 
phenotypes are the net result of deleterious and beneficial NEFA-induced processes. See text 
for further details.  
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 7 
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Figure 9 
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